Rivastigmine Hydrogen Tartrate

Rivastigmine hydrogen tartrate is a cholinesterase inhibitor used primarily to treat Alzheimer’s and Parkinson’s diseases by slowing the breakdown of acetylcholine, a neurotransmitter involved in memory and cognitive function. This compound works by enhancing communication between nerve cells, helping to manage symptoms and improve patients’ cognitive abilities.

Amber Lifesciences, a certified global supplier based in India, offers Rivastigmine hydrogen tartrate to support your research, development, and commercial needs. We ensure the highest quality standards through a trusted network of manufacturers, providing you with reliable and cost-effective solutions.